Publications by authors named "Jiu-wei Cui"

Claim this Profile
G
Ginsenoside Rh2 mitigates hepatic gluconeogenesis by regulating Akt/FoxO1 pathway in type 2 diabetic mice.
Ya-Qian Gao, Yong-Bo Liu, Xu-Fei Gao, Shen Ren, Shan Tang, Jiu-Wei Cui

Int Immunopharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, An-Wen Liu, Guo-Wu Wu, Jiu-Wei Cui

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A convenient calf proportion index calculator for survival prediction in overweight and obese patients with cancer.
Jia-Xin Huang, Xi Zhang, Wen-Jie Zhu, Meng Tang, Chun-Hua Song, Jiu-Wei Cui

Obes Res Clin Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia.
Kai-Lun Zhang, Ming-Ming Zhou, Kun-Hua Wang, Min Weng, Fu-Xiang Zhou, Jiu-Wei Cui

Nutrition· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between GLIM-diagnosed malnutrition and quality of life in older patients with cancer.
Zhang Xi, Huang Jia-Xin, Wu Xi, Tang Meng, Liu Jin-Feng, Cui Jiu-Wei

J Nutr Health Aging· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers.
Feng-Min Zhang, Chun-Hua Song, Zeng-Qing Guo, Zhen Yu, Min Weng, Jiu-Wei Cui

Nutrition· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and dose selection of AZD3759 in patients with untreated -mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, Yingying Du, Jiu-Wei Cui

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial.
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, Hong-Hong Yan, Xiao-Rong Dong, Jiu-Wei Cui

Nat Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of fat-free mass index and appendicular skeletal muscle mass index in cancer malnutrition: a propensity score match analysis.
Wei Ji, XiangLiang Liu, Pengfei Liu, YuWei He, YiXin Zhao, JiuWei Cui

Front Nutr· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.
Yin Liu, Xiu-Zhi Zhu, Yi Xiao, Song-Yang Wu, Wen-Jia Zuo, Jiu-Wei Cui

Cell Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients.
Lei Qian, Xiao Ding, Fang-Qi Li, Hui-Min Tian, Xiao Chen, Jiu-Wei Cui

Neoplasma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705).
Si-Yang Maggie Liu, Hong-Hong Yan, Xue-Wu Wei, Chang Lu, Xiao-Rong Dong, Jiu-Wei Cui

Clin Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer.
Fang-Qi Li, Jiu-Wei Cui

Crit Rev Oncol Hematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Formulas for Calculating L3 Skeletal Muscle Mass Index and Visceral Fat Area Based on Anthropometric Parameters.
Wei Ji, XiangLiang Liu, Yiqun Zhang, Yixin Zhao, YuWei He, JiuWei Cui

Front Nutr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thresholds of visceral fat area and percent of body fat to define sarcopenic obesity and its clinical consequences in Chinese cancer patients.
Wei Ji, XiangLiang Liu, KaiWen Zheng, PengFei Liu, YiXin Zhao, JiuWei Cui

Clin Nutr· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Ri-Lan Bai, Nan-Ya Wang, Ling-Ling Zhao, Yong-Fei Zhang, Jiu-Wei Cui

Hepatobiliary Pancreat Dis Int· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulating monocyte infiltration and differentiation: Providing new therapies for colorectal cancer patients with COVID-19.
Ling Bai, Wang Yang, Lei Qian, Jiu-Wei Cui

World J Clin Cases· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Qing Zhou, Chong-Rui Xu, Ying Cheng, Yun-Peng Liu, Gong-Yan Chen, Jiu-Wei Cui

Cancer Cell· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma.
Xiang-Liang Liu, Ri-Lan Bai, Xiao Chen, Yu-Guang Zhao, Xu Wang, Jiu-Wei Cui

Chin Med J (Engl)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options.
Jiu-Wei Cui, Qing Zhou, Shun Lu, Ying Cheng, Jie Wang

Transl Lung Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.
Wen-Qian Li, Han-Fei Guo, Ling-Yu Li, Yong-Fei Zhang, Jiu-Wei Cui

Cancer Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brand new era of cancer immunotherapy: breakthroughs and challenges.
Ri-Lan Bai, Nai-Fei Chen, Ling-Yu Li, Jiu-Wei Cui

Chin Med J (Engl)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of phase angle with sarcopenia and its diagnostic value in elderly men with cancer.
Wei Ji, XiangLiang Liu, KaiWen Zheng, HaiMei Yang, JiuWei Cui

Nutrition· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of first-line treatments for advanced epidermal growth factor receptor-mutant non-small cell lung cancer patients.
Wen-Qian Li, Ling-Yu Li, Jin Chai, Jiu-Wei Cui

Cancer Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy.
Qing Zhou, Ming Chen, Gang Wu, Jian-Hua Chang, Ou Jiang, Jiu-Wei Cui

Transl Lung Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis